SCHEMBL23639734

SCHEMBL23639734

CCOC(=O)Cc1cn2cc(C(F)(F)F)ccc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 5/20 0.47
POLB P06746 4/20 0.47
KDM4E B2RXH2 8/20 0.45
ALDH1A1 P00352 6/20 0.45
NPC1 O15118 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
MAPT P10636 2/20 0.45
METTL3 Q86U44 1/20 0.44
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
GFER P55789 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
RCE1 Q9Y256 1/20 0.43
MEN1 O00255 1/20 0.42
ESR1 P03372 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
ESR2 Q92731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15068790 0.84 KDM4E (0.49) POLBKDM4EALDH1A1NPC1HPGD
SCHEMBL23639582 0.83 KDM4E (0.50) POLBKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL4822612 0.81 KDM4E (0.47) POLBKDM4EALDH1A1NPC1HPGD
SCHEMBL3883777 0.81 KDM4E (0.60) POLBKDM4EALDH1A1NPC1HPGD
SCHEMBL7982714 0.81 KDM4E (0.44) POLBKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL15068509 0.81 KDM4E (0.56) POLBKDM4EALDH1A1NPC1SMN1; SMN2
SCHEMBL26611036 0.80 KDM4E (0.42) POLBKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL29381830 0.79 HDAC4 (0.57)
SCHEMBL22277159 0.78 KDM4E (0.50) MCHR1POLBKDM4EALDH1A1NPC1
SCHEMBL12618991 0.78 KDM4E (0.45) POLBKDM4EALDH1A1NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240008488-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-01-11 US disclosed
EP-4223755-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-08-09 EP disclosed
WO-2021141106-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME 住友化学株式会社 2021-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240008488-A1 HETEROCYCLIC COMPOUND AND HARMFUL ARTHROPOD-CONTROLLING COMPOSITION INCLUDING SAME C5, C1QBP, C3AR1 MCHR1 734/4885POLB 2260/4885KDM4E 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.